PD L1 News and Research

RSS
Molecular drivers and emerging treatments in anaplastic thyroid cancer

Molecular drivers and emerging treatments in anaplastic thyroid cancer

Some lung cancer patients maintain long-term control after stopping immunotherapy

Some lung cancer patients maintain long-term control after stopping immunotherapy

Understanding the role of iron-dependent ferroptosis in immune suppression

Understanding the role of iron-dependent ferroptosis in immune suppression

Circadian rhythms play a crucial role of in regulating tumor progression

Circadian rhythms play a crucial role of in regulating tumor progression

Cleveland Clinic study reveals insights on immune checkpoint inhibitors for colorectal cancer

Cleveland Clinic study reveals insights on immune checkpoint inhibitors for colorectal cancer

Combination immunotherapy improves treatment response for head and neck cancer

Combination immunotherapy improves treatment response for head and neck cancer

Researchers discover race-associated molecular differences in pancreatic tumors

Researchers discover race-associated molecular differences in pancreatic tumors

Deciphering the tumor-immune interplay in endometrial carcinoma

Deciphering the tumor-immune interplay in endometrial carcinoma

Unraveling the genetic differences between LUAD and LUSC in lung cancer

Unraveling the genetic differences between LUAD and LUSC in lung cancer

Novel treatment approach shows promise for advanced HPV-negative head and neck cancer

Novel treatment approach shows promise for advanced HPV-negative head and neck cancer

Study unravels the complex interplay of the UPS in cancer development and treatment

Study unravels the complex interplay of the UPS in cancer development and treatment

CPRIT awards nearly $23 million to MD Anderson for cancer research projects

CPRIT awards nearly $23 million to MD Anderson for cancer research projects

Radiation and immunotherapy help preserve bladders in patients with muscle-invasive bladder cancer

Radiation and immunotherapy help preserve bladders in patients with muscle-invasive bladder cancer

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

New dual-target therapy offers hope for better breast cancer treatment

New dual-target therapy offers hope for better breast cancer treatment

Microbes in your gut could determine cancer treatment outcomes

Microbes in your gut could determine cancer treatment outcomes

Stanford researchers develop AI model to enhance cancer prognosis predictions

Stanford researchers develop AI model to enhance cancer prognosis predictions

AI-based SCORPIO tool offers better cancer immunotherapy predictions

AI-based SCORPIO tool offers better cancer immunotherapy predictions

New nanoparticle platform delivers drug pairs to specific cancer types

New nanoparticle platform delivers drug pairs to specific cancer types

Exosomes: A double-edged sword in hepatocellular carcinoma

Exosomes: A double-edged sword in hepatocellular carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.